News & Media

Blog

Pepper Bio hopes to challenge Eroom’s law with new funding

Whether you are a tech optimist or not, you have to acknowledge that progress rarely follows a straight line. While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn’t getting cheaper. Some hope that AI can help, and it likely will — when it comes to biotech, it is much more than a buzzword.  But Boston-based drug discovery…

0 Comments
November 30, 2023
Read more about the article Overcoming EGFRi Resistance Through Transomic Analyses
Blog

Overcoming EGFRi Resistance Through Transomic Analyses

Pepper Bio is on a mission to put an end to untreatable diseases by enabling more effective drug discovery through the use of transomic analysis. We do this using our COMPASS platform that integrates data across the genomic, transcriptomic, proteomic, and phosphoproteomic biological layers to uncover global, functional and causal understanding of complex biological processes. At the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference, hosted by the American Association…

Comments Off on Overcoming EGFRi Resistance Through Transomic Analyses
October 13, 2023
Podcast

Podcast: Unlocking the Potential of Transomics in Biotech

In this enlightening episode, the Artificial Intelligence podcast sat down with Samantha Dale Strasser, the co-founder and CSO of Pepper Bio, a pioneering company in the world of transomics drug discovery. Discover the vital role of phosphoproteomic data, the challenges and innovations in integrating multiple -omics layers, and how AI is set to revolutionize clinical trials and drug discovery. Join us on this journey as we explore the foundation of…

Comments Off on Podcast: Unlocking the Potential of Transomics in Biotech
September 25, 2023
Podcast

Podcast: Using Transomics In Drug Discovery

Samantha Dale Strasser is the Chief Science Officer and co-founder of Pepper Bio. Pepper Bio is the world's first transomics analysis company. Transomics involves analyzing a wealth of biological information from genomics all the way up to more functional data of phosphoproteomics. Pepper Bio is able to see more relevant disease insights about how to best treat disease and how to characterize potential drugs that can be used as therapeutics.…

Comments Off on Podcast: Using Transomics In Drug Discovery
June 10, 2023
Read more about the article The future of biomedical research is animal-free
Blog

The future of biomedical research is animal-free

As a scientist focused on tangible data and results, it’s easy to be sceptical about the impact of legislative acts: the path from Congress to the lab is long and winding. Despite the subtle change and lack of immediate impact on patients, the FDA Modernization Act 2.0 is anything but inconsequential. I think, in truth, that it may be the spark needed to ignite the next era of animal-free drug…

Comments Off on The future of biomedical research is animal-free
May 11, 2023
Podcast

Podcast: Building Careers in Biotech

"As a PhD, you're very focused on the question and the process of how you get things done. Our focus [as a Biotech company] is on what impact we want to have, where we're going and the key questions that our partners are trying to answer." Samantha Dale Strasser is the Chief Scientific Officer of Pepper Bio, the world's first transomic analysis company. Samantha joined us in a fascinating discussion…

Comments Off on Podcast: Building Careers in Biotech
May 10, 2023